SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-012442
Filing Date
2024-04-18
Accepted
2024-04-18 16:21:35
Documents
18
Period of Report
2024-04-18
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pirs20240401_8k.htm   iXBRL 8-K 46168
2 EXHIBIT 3.1 ex_655548.htm EX-3.1 1418
3 EXHIBIT 99.1 ex_655549.htm EX-99.1 10857
8 ex03.jpg GRAPHIC 342738
9 ex_655549img001.jpg GRAPHIC 2201
  Complete submission text file 0001437749-24-012442.txt   681804

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pirs-20240418.xsd EX-101.SCH 3409
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pirs-20240418_def.xml EX-101.DEF 12187
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE pirs-20240418_lab.xml EX-101.LAB 16396
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pirs-20240418_pre.xml EX-101.PRE 12457
21 EXTRACTED XBRL INSTANCE DOCUMENT pirs20240401_8k_htm.xml XML 3052
Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 24854561
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)